PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity
Abstract Fat accumulation, de novo lipogenesis, and glycolysis are key drivers of hepatocyte reprogramming and the consequent metabolic dysfunction-associated steatotic liver disease (MASLD). Here we report that obesity leads to dysregulated expression of hepatic protein-tyrosine phosphatases (PTPs)...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Portfolio
2024-11-01
|
| Reeks: | Nature Communications |
| Online toegang: | https://doi.org/10.1038/s41467-024-53733-0 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
